66 results
8-K
TVTX
Travere Therapeutics Inc
24 Apr 24
Other Events
4:05pm
health epidemics and pandemics, including risks related to potential disruptions to clinical trials, commercialization activity, supply chain
8-K
TVTX
Travere Therapeutics Inc
23 Feb 24
Other Events
4:05pm
related to potential disruptions to clinical trials, commercialization activity, supply chain, and manufacturing operations.
In addition, such risks
8-K
EX-99.1
TVTX
Travere Therapeutics Inc
15 Feb 24
Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
related to potential disruptions to clinical trials, commercialization activity, supply chain, and manufacturing operations. You are cautioned not to place
8-K
EX-99.1
sohmafuiuyf3lcdcls
8 Jan 24
Travere Therapeutics Provides Corporate Update and 2024 Outlook
7:07am
8-K
z45p55j 1t
4 Dec 23
Cost Associated with Exit or Disposal Activities
4:10pm
8-K
EX-99.1
x8s6eqj6nz9 54lz
7 Nov 23
Travere Therapeutics Reports Third Quarter 2023 Financial Results
4:04pm
8-K
8mv400uc0il1l377z21
21 Sep 23
Other Events
7:35am
8-K
EX-99.1
o6j8q 4afht
3 Aug 23
Travere Therapeutics Reports Second Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
wueu15p
22 May 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
qro4g
4 May 23
Travere Therapeutics Reports First Quarter 2023 Financial Results
4:05pm
8-K
ahnmh 17jkof3z4al
1 May 23
Other Events
4:07pm